The RCSI Department of Pathology, based at the RCSI Smurfit Building, Beaumont Hospital, is responsible for Undergraduate and Postgraduate teaching in pathology, the mentoring of students, research and contributing to the national and international developments in surgical pathology, research and education.
The department has close links with the Department of Diagnostic Histopathology in Beaumont Hospital; hence, the consultant histopathologists in Beaumont contribute extensively to the teaching of RCSI students.
- Telephone: +353 1 809 2541
- Email: email@example.com
The educational aim of the department is to provide a relevant, clinically-based pathology module that allows students to recognise the value of pathology, (including molecular pathology) to their understanding of medicine.
Pathology for RCSI Undergraduate students includes lectures, small group teaching sessions in the format of clinicopathological conference teaching, tutorials and clinical laboratory sessions. Additionally, an online learning module is available to all students – this includes tutorials, images and self-assessment. All teaching is provided by medically-qualified staff, many of whom have postgraduate memberships in medicine and surgery and other disciplines.
At Postgraduate level, training is provided to trainee pathologists in both RCSI and Beaumont Hospital. This training programme is linked to the North Dublin rotation programme and is accredited by the RCPI. Special tutorials are provided for non-consultant hospital doctors participating in postgraduate professional examinations.
The Department of Pathology has also had significant involvement in the postgraduate training of surgeons in sub-Saharan Africa through its participation in COSECSA (College of Surgeons of Eastern Central and Southern Africa).
The research activities of the Department of Pathology are centred on molecular and cancer-based translational research. We have a particular focus on breast, colorectal and prostate cancer research and have developed a wide variety of testing strategies designed to answer important clinical questions in the areas of prediction, diagnosis, prognosis, monitoring and provision of targeted therapies, all to improve patient outcomes.
The Pathology laboratory processes over 20,000 tissue samples per annum and functions as a core facility for translational molecular research programmes for investigators throughout RCSI including the Departments of Surgery, Molecular & Cellular Therapeutics and Molecular Medicine. Ongoing academic collaborations are also in place with researchers in Trinity College Dublin, University College Dublin and Queen's University Belfast, plus industry partnerships with ALMAC, Leica Microsystems, OncoMark, Nuritas, Astrazeneca and Roche.
The Pathology Department also plays a significant role in international quality assurance programmes in conjunction with the UK National External Quality Assessment Scheme. Members of the department have been at the forefront of the development of molecular genetics and immunocytochemistry-based quality assurance programmes for the past decade.
The department also houses and manages the RCSI Biobank consisting of sample collection, processing, storage, distribution and data management. The laboratory provides high-quality specimens with accurate, reliable, standardised clinical and laboratory data to researchers involved in high impact basic, translational, clinical and population sciences.
- Mary Leader
- Tony Dorman
Academic Senior Lecturer
- Maeve Redmond
Honorary Senior Lecturers
- Helen Barrett
- Mary Keogan
- Philip Murphy
- Alan Beausang
- Francesca Brett
- Jane Cryan
- Brendan Doyle
- Michael Farrell
- Anne-Marie O’Shea
- Marie Staunton